Cargando…

Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment

INTRODUCTION: Accurate delivery of radiation while reducing dose to organs at risk is essential in prostate treatment. The Calypso motion management system detects and corrects both inter‐ and intra‐fraction motion which offers potential benefits over standard alignment to fiducial markers. The aims...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Linda J., Eade, Thomas, Kneebone, Andrew, Hruby, George, Alfieri, Florencia, Bromley, Regina, Grimberg, Kylie, Barnes, Mardi, Booth, Jeremy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355366/
https://www.ncbi.nlm.nih.gov/pubmed/28263041
http://dx.doi.org/10.1002/jmrs.224
_version_ 1782515546573504512
author Bell, Linda J.
Eade, Thomas
Kneebone, Andrew
Hruby, George
Alfieri, Florencia
Bromley, Regina
Grimberg, Kylie
Barnes, Mardi
Booth, Jeremy T.
author_facet Bell, Linda J.
Eade, Thomas
Kneebone, Andrew
Hruby, George
Alfieri, Florencia
Bromley, Regina
Grimberg, Kylie
Barnes, Mardi
Booth, Jeremy T.
author_sort Bell, Linda J.
collection PubMed
description INTRODUCTION: Accurate delivery of radiation while reducing dose to organs at risk is essential in prostate treatment. The Calypso motion management system detects and corrects both inter‐ and intra‐fraction motion which offers potential benefits over standard alignment to fiducial markers. The aims of this study were to implement Calypso with Dynamic Edge™ gating and to assess both the motion seen, and interventions required. METHODS: An implementation group was formed which assessed changes needed to standard workflows. Three patients had Calypso beacons inserted into their prostate. All patients were treated using volumetric modulated arc therapy to a dose of 80 Gy in 40 fractions. Standard inter‐fraction motion correction using either kilovoltage (kV) orthogonal paired imaging or cone beam computed tomography (CBCT) image‐guided radiotherapy techniques, were used along with the Calypso system to compare accuracy. A gating threshold of >0.5 cm was used during treatment. Workflow variations along with inter‐ and intra‐fraction motion and interventions required were assessed. RESULTS: A total of 116 fractions were treated using Calypso with Dynamic Edge™ gating. There was a strong concordance between aligning beacons using kV orthogonal imaging or CBCT and Calypso (mean variation ≤0.06 cm). The mean intra‐fraction motion detected was ≤0.2 cm in all directions with the largest motion recorded being 2.2 cm in the left direction while the treatment beam was off. Prostate rotation was largest in the pitch direction and 28 fractions exceeded the 10° tolerance. A total of 78 couch shift corrections of ≥0.3 cm were required, usually following standard imaging, and before treatment starting. Three gating events due to intra‐fraction motion occurred during treatment. CONCLUSIONS: Intra‐fraction motion monitoring with Calypso was successfully implemented. Greatest movement was seen between time of standard imaging and treatment starting with more than half the treatments requiring a ≥0.3 cm adjustment. This would not have been detected without intra‐fraction monitoring.
format Online
Article
Text
id pubmed-5355366
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53553662017-03-22 Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment Bell, Linda J. Eade, Thomas Kneebone, Andrew Hruby, George Alfieri, Florencia Bromley, Regina Grimberg, Kylie Barnes, Mardi Booth, Jeremy T. J Med Radiat Sci Original Articles INTRODUCTION: Accurate delivery of radiation while reducing dose to organs at risk is essential in prostate treatment. The Calypso motion management system detects and corrects both inter‐ and intra‐fraction motion which offers potential benefits over standard alignment to fiducial markers. The aims of this study were to implement Calypso with Dynamic Edge™ gating and to assess both the motion seen, and interventions required. METHODS: An implementation group was formed which assessed changes needed to standard workflows. Three patients had Calypso beacons inserted into their prostate. All patients were treated using volumetric modulated arc therapy to a dose of 80 Gy in 40 fractions. Standard inter‐fraction motion correction using either kilovoltage (kV) orthogonal paired imaging or cone beam computed tomography (CBCT) image‐guided radiotherapy techniques, were used along with the Calypso system to compare accuracy. A gating threshold of >0.5 cm was used during treatment. Workflow variations along with inter‐ and intra‐fraction motion and interventions required were assessed. RESULTS: A total of 116 fractions were treated using Calypso with Dynamic Edge™ gating. There was a strong concordance between aligning beacons using kV orthogonal imaging or CBCT and Calypso (mean variation ≤0.06 cm). The mean intra‐fraction motion detected was ≤0.2 cm in all directions with the largest motion recorded being 2.2 cm in the left direction while the treatment beam was off. Prostate rotation was largest in the pitch direction and 28 fractions exceeded the 10° tolerance. A total of 78 couch shift corrections of ≥0.3 cm were required, usually following standard imaging, and before treatment starting. Three gating events due to intra‐fraction motion occurred during treatment. CONCLUSIONS: Intra‐fraction motion monitoring with Calypso was successfully implemented. Greatest movement was seen between time of standard imaging and treatment starting with more than half the treatments requiring a ≥0.3 cm adjustment. This would not have been detected without intra‐fraction monitoring. John Wiley and Sons Inc. 2017-03-06 2017-03 /pmc/articles/PMC5355366/ /pubmed/28263041 http://dx.doi.org/10.1002/jmrs.224 Text en © 2017 The Authors. Journal of Medical Radiation Sciences published by Wiley Publishing Asia Pty Ltd on behalf of Australian Society of Medical Imaging and Radiation Therapy and New Zealand Institute of Medical Radiation Technology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Bell, Linda J.
Eade, Thomas
Kneebone, Andrew
Hruby, George
Alfieri, Florencia
Bromley, Regina
Grimberg, Kylie
Barnes, Mardi
Booth, Jeremy T.
Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment
title Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment
title_full Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment
title_fullStr Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment
title_full_unstemmed Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment
title_short Initial experience with intra‐fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment
title_sort initial experience with intra‐fraction motion monitoring using calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355366/
https://www.ncbi.nlm.nih.gov/pubmed/28263041
http://dx.doi.org/10.1002/jmrs.224
work_keys_str_mv AT belllindaj initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT eadethomas initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT kneeboneandrew initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT hrubygeorge initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT alfieriflorencia initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT bromleyregina initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT grimbergkylie initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT barnesmardi initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment
AT boothjeremyt initialexperiencewithintrafractionmotionmonitoringusingcalypsoguidedvolumetricmodulatedarctherapyfordefinitiveprostatecancertreatment